Successful use of olorofim for the treatment of <i>Lomentospora prolificans</i> knee tendonitis, synovitis, and concomitant osteomyelitis in an immunocompetent child

<i>Lomentospora prolificans</i> is a filamentous mold that can cause infections in both immunocompromised and immunocompetent individuals. Infection can be either focal or disseminated, often acquired via inhalation or direct conidia inoculation (A. Konsoula, C. Tsioutis, I. Markaki, M. Papadakis, A.P. Agouridis, N. Spernovasilis. Microorganisms 10:1317, 2022, https://doi.org/10.3390/microorganisms10071317). This pathogen is challenging to treat due to its high MICs to available antifungals. We present a case of an 8-year-old previously healthy female who developed <i>L. prolificans</i> knee tendonitis and synovitis with patellar osteomyelitis after a flat patio stone laceration in Southern California, who ultimately was treated with the novel antifungal, olorofim.

Authors

Institutions

Publication Details

Journal
Antimicrobial Agents and Chemotherapy
Published
2025-08-27
DOI
https://doi.org/10.1128/aac.00602-25
Citations
2
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
2.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful use of olorofim for the treatment of Lomentospora prolificans knee tendonitis, synovitis, and concomitant osteomyelitis in an immunocompetent child

Tristan R. Grams, Trahern W. Jones, Mary B. Fortini, Sonia Mehra
2 citations
Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibility
2.79
article

Successful use of olorofim for the treatment of Lomentospora prolificans knee tendonitis, synovitis, and concomitant osteomyelitis in an immunocompetent child

Tristan R. Grams, Trahern W. Jones, Mary B. Fortini, Sonia Mehra
article en
2 citations

Abstract

<i>Lomentospora prolificans</i> is a filamentous mold that can cause infections in both immunocompromised and immunocompetent individuals. Infection can be either focal or disseminated, often acquired via inhalation or direct conidia inoculation (A. Konsoula, C. Tsioutis, I. Markaki, M. Papadakis, A.P. Agouridis, N. Spernovasilis. Microorganisms 10:1317, 2022, https://doi.org/10.3390/microorganisms10071317). This pathogen is challenging to treat due to its high MICs to available antifungals. We present a case of an 8-year-old previously healthy female who developed <i>L. prolificans</i> knee tendonitis and synovitis with patellar osteomyelitis after a flat patio stone laceration in Southern California, who ultimately was treated with the novel antifungal, olorofim.

Antimicrobial Agents and ChemotherapyVol. 69(11)
Primary Children's Hospital (US), University of Utah (US), University of Utah Hospital (US)
Openalex Percentile: Top 9%
Antifungal resistance and susceptibility
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Successful use of olorofim for the treatment of <i>Lomentospora prolificans</i> knee tendonitis, synovitis, and concomitant osteomyelitis in an immunocompetent child — Tristan R. Grams, Trahern W. Jones, et al. · Antimicrobial Agents and Chemotherapy (2025) | TGRS Research Map | TGRS